Key financial metrics and fundamentals for Contineum Therapeutics, Inc. Class A Common Stock (CTNM).
Market Cap
$518.2M
P/E Ratio
-8.85
Forward P/E
--
EPS
$-1.57
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High